Showing results (381-390 of 464) with videos related to
Sort By:
Pageof 47
Oncotarget|December 24, 2015
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cellsElizabeth M Matthew, Lanlan Zhou, Zhaohai Yang, et al.Human Pathology|April 1, 1996
The WAF1-mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipientsI O Baas, J A Offerhaus, W S El-Deiry, et al.Frontiers in Oncology|May 24, 2021
Corrigendum: Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty ClinicPooja Ghatalia, Chad H Smith, Arthur Winer, et al.Cell Reports|November 11, 2025
Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistanceGatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, et al.Frontiers in Oncology|February 2, 2019
Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty ClinicPooja Ghatalia, Chad H Smith, Arthur Winer, et al.Cancer Biology & Therapy|April 26, 2007
IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanismsMunenori Takaoka, Seok-Hyun Kim, Takaomi Okawa, et al.Clinical Colorectal Cancer|January 28, 2014
Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimensChristina Leah B Kline, Angelique Schiccitano, Junjia Zhu, et al.Science Translational Medicine|February 8, 2013
Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effectsJoshua E Allen, Gabriel Krigsfeld, Patrick A Mayes, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.The Journal of Molecular Diagnostics : JMD|September 25, 2021
Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer TypesAndrew Elliott, Jian Zhang, Qing Zhang, et al.Pageof 47